Data as of Sep 14, 2026 · Based on 3,293,187 AI responses across 10,525 prompts · See how Parse measures this
Grifols Plasmagrifols.comGrifols is a global health company that develops, manufactures, and markets innovative medicines, plasma-derived therapies, diagnostics, and hospital solutions across more than 110 countries. Its key areas include immunology, hepatology and intensive care, pulmonology, hematology, neurology, infectious diseases, and other opportunities, supported by extensive plasma science and programs like CHRONOS-PD. The company emphasizes sustainability, ethics, and social commitment, including supporting patients and plasma donors, and maintains a broad R&D network to drive future breakthroughs.
The market map · 5 of 63 labelled
Biotech and Health Service Providers →23%positive
Where Grifols Plasma ranks in AI
massive global networkoperates many centersmassivevarieslarge networkmajor operatorsliding-scale compensationmajor international operator
Octapharma Plasmaco-mentionedCompare →Excerpts where Grifols Plasma appeared in the AI's answer
Grifols Plasma operates under various regional names including Biomat USA and Talecris Plasma Resources
Grifols Plasma operates under various regional names including ... Talecris Plasma Resources
